← Back to Search

Informational Meetings for Cancer Care Coordination (IMPACT Trial)

N/A
Recruiting
Led By Joan E Haase, PhD
Research Sponsored by Joan E. Haase
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child aged 1 month to under 18 years
Falls into specific diagnosis categories such as atypical teratoid rhabdoid tumor, glioblastoma multiforme, etc.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up enrollment, then every 4 months until death or maximum of 4 years
Awards & highlights

IMPACT Trial Summary

This trial is testing a new way for doctors and nurses to talk to parents of children with cancer, to help them better understand and align with the child's goals for treatment. They hope this will improve quality of life outcomes, especially for those children who do not survive.

Who is the study for?
This trial is for parents of children (1 month to <18 years) with cancer and a poor prognosis. The child must provide assent if ≥7 years old. It includes various diagnoses like high-grade gliomas and metastatic sarcomas, among others. Parents must be legal decision-makers, informed about the diagnosis, speak English, and agree to audio recordings during study sessions.Check my eligibility
What is being tested?
The trial tests a new communication strategy by physician-nurse teams aimed at aligning treatment goals with parental expectations to potentially improve quality of life for children facing end-of-life situations due to cancer.See study design
What are the potential side effects?
Since this intervention focuses on communication rather than medical treatments or drugs, there are no traditional side effects; however, emotional or psychological impacts may arise from discussions about end-of-life care.

IMPACT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 1 month and 18 years old.
Select...
My diagnosis is a specific type of brain tumor.

IMPACT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment, then every 4 months until death or maximum of 4 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and enrollment, then every 4 months until death or maximum of 4 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Impact of Novel Communication Intervention on number of days enrolled in hospice in children with cancer and estimated 5-year survival < 25%
Secondary outcome measures
Impact of Novel Communication Intervention on parental adjustment to caring for a child with cancer.
Impact of Novel Communication Intervention on parental satisfaction with healthcare
Impact of Novel Communication Intervention on quality of life in children with cancer and estimated 5-year survival < 25%
+2 more

IMPACT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Novel Communication InterventionExperimental Treatment1 Intervention
Parent(s) and patients receiving care from clinicians whose practice has been randomized to the novel communication intervention group.
Group II: Enhanced Usual Care Parent EducationActive Control1 Intervention
Parent(s) and patients receiving care from clinicians whose practice has been randomized to the enhanced usual care parent education group.

Find a Location

Who is running the clinical trial?

Joan E. HaaseLead Sponsor
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,501 Total Patients Enrolled
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
982,995 Total Patients Enrolled

Media Library

Novel Communication Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04330833 — N/A
Cancer Research Study Groups: Enhanced Usual Care Parent Education, Novel Communication Intervention
Cancer Clinical Trial 2023: Novel Communication Intervention Highlights & Side Effects. Trial Name: NCT04330833 — N/A
Novel Communication Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04330833 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the clinical trial extend to those who are of advanced age?

"The requirements for entry into this clinical trial stipulate that the minimum age of participants must be at least one month old, while the cutoff for eligibility is 17 years."

Answered by AI

Who meets the prerequisites for involvement in this clinical investigation?

"The requisite qualifications for this research are being able to communicate and having an age between 1 Month and 17 years. A total of 166 people will be recruited into the study."

Answered by AI

How many locations are participating in the clinical trial within the city?

"Currently, 6 medical centres are accepting participants for this trial. These sites reside in Wilmington, Aurora and Milwaukee with three other unspecified locations spread out geographically. To ease the burden of a long journey, it would be wise to choose one closest to you if you opt-in."

Answered by AI

What is the current participant capacity for this investigation?

"The project requires 166 individuals, who meet the necessary criteria, to take part. People can partake in this trial at a number of locations including Nemours Children's Health (Wilmington, Delaware) and Children's Hospital Colorado (Aurora, Colorado)."

Answered by AI

Is there currently an open call for participants in this research?

"Affirmative. Clinicaltrials.gov's information shows us that, as of July 27th 2022, this clinical trial is still recruiting candidates; it was originally posted on December 8th 2020. 166 participants are required to be sourced from 6 medical facilities."

Answered by AI
Recent research and studies
~36 spots leftby Apr 2025